Loading clinical trials...
Loading clinical trials...
Collecting Real-world Data on Endoscopic and Histopathological Outcomes of Screening and Surveillance Colonoscopies for the Development of a CAD (Computer Aided Detection) System: A Prospective, Multicenter, Post-market Investigation
The objective of this study is to collect colonoscopy data for use in the development and testing of artificial intelligence (AI) devices for colonoscopies.
The primary objective of this study is to collect colonoscopy data for use in the development and performance evaluation of AI devices. The data will be collected during routine colonoscopy procedures. Biopsy or resection will be performed if needed and all specimens will be sent for histopathological examination. The histopathological results will be recorded.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
End- und Dickdarmzentrum Hannover
Hanover, Germany
Hospital Universitario Ramón y Cajal
Madrid, Spain
Start Date
March 12, 2024
Primary Completion Date
October 30, 2025
Completion Date
October 30, 2025
Last Updated
March 6, 2026
600
ACTUAL participants
Colonoscopy
DEVICE
Lead Sponsor
Olympus Europe SE & Co. KG
NCT06550908
NCT07089615
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06063720